Multiple Sclerosis News
- Biosimilar Equal to Natalizumab for Relapsing-Remitting MS
- Despite Challenges, Experts Optimistic About MS Therapy's Future
- Flu, Other Common Viruses Linked to Neurologic Conditions
- Experts Demand Validation of Automatic Blood Pressure Devices
- Add This to the List of Long COVID Symptoms: Stigma
- Mediterranean Diet Linked With Fewer Pregnancy Complications
- FDA OKs TG Therapeutics' Multiple Sclerosis Drug; Shares Surge
- Stem Cell Transplant Superior to Meds for Secondary Progressive MS
- MCL: Event-Free Survival at 2 Years Bodes Well
- Two Traditional Chinese Therapies Better Together for Neck Pain
- RSNA 2022 Corticosteroid Injections May Worsen Knee OA Progression
- ASH 2022 ITP: Biologic Beat Placebo, but Few Patients Improved
- ASH 2022 MCL: Ibrutinib Could Become the 'New Standard'
- How Fitness Trackers Will Help Us Keep an Eye on Disease
- Placebo Effect a Major Driver of Pain Reduction in Cannabis Trials
- Postpartum Hemorrhage Rates and Risk Factors Rising
- Physicians React: On Access to Quality, Affordable Healthcare
- High Neuro Drug Costs Exclude Most From Cutting-Edge Tx
- Ozempic Shortage; New MS Framework; and AI in Drug Trials
- Colorado Tries to Fill Health Worker Gaps With Apprenticeships